Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam.
Zacher
Jennifer L
JL
Roche-Desilets
Jennifer
J
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D017277:Drug Approval; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D007022:Hypotension / Q000139:chemically induced*; D007273:Injections, Intramuscular; D008140:Lorazepam / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D014481:United States
D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D001569:Benzodiazepines; D000077152:Olanzapine; D008140:Lorazepam